# Atomoxetine in Veterans With Comorbid ADHD/PTSD

> **NCT02287038** · PHASE4 · COMPLETED · sponsor: **VA Office of Research and Development** · enrollment: 44 (actual)

## Conditions studied

- Post Traumatic Stress Disorder
- Attention Deficit Hyperactivity Disorder

## Interventions

- **DRUG:** Atomoxetine 80 MG

## Key facts

- **NCT ID:** NCT02287038
- **Lead sponsor:** VA Office of Research and Development
- **Sponsor class:** FED
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-10-15
- **Primary completion:** 2017-03-02
- **Final completion:** 2017-04-14
- **Target enrollment:** 44 (ACTUAL)
- **Last updated:** 2019-04-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02287038

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02287038, "Atomoxetine in Veterans With Comorbid ADHD/PTSD". Retrieved via AI Analytics 2026-09-03 from https://api.ai-analytics.org/clinical/NCT02287038. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*